Cell-Permeable Peptide Inhibitor of c-Jun NH2-Terminal Kinase for the Treatment of Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|6|1|23-30

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.6, Iss.1, 2010-03, pp. : 23-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of stress-associated scaffold proteins JIP1 and JIP3 on the c-Jun NH2-terminal kinase in ischemia-reperfusion

By Xu Bing   Zhou Yaling   O Karmin   Choy Patrick C.   Pierce Grant N.   Siow Yaw L.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 11, 2010-11 ,pp. : 1084-1092

NRC Research Press

Access to resources Recommend Favorite

Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase

By Palin K.   McCusker R.   Strle K.   Moos F.   Dantzer R.   Kelley K.  

Psychopharmacology, Vol. 197, Iss. 4, 2008-05 ,pp. : 629-635

Springer Publishing Company

Access to resources Recommend Favorite

Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants

By Zhang Guang-Yi   Zhang Quan-Guang  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1373-1383

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of c-jun-N-Terminal Kinase (JNK)

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 8, 2008-07 ,pp. : 755-766

Bentham Science Publishers

Access to resources Recommend Favorite

Hydrogen peroxide inhibits the immune response to lipopolysaccharide by attenuating signaling through c-Jun N-terminal kinase and p38 associated with protein kinase C

By Lee M.   Yea S.S.  

Immunopharmacology, Vol. 48, Iss. 2, 2000-07 ,pp. : 165-172

Elsevier

Access to resources Recommend Favorite